Hims & Hers Health Inc ( HIMS ) shares are trading 1.7% lower at $40.13 Monday morning. The company earlier appointed Nader Kabbani as its new Chief Operations Officer, signaling a strategic push to scale its personalized healthcare platform.

The announcement comes ahead of Hims & Hers' first-quarter earnings release after the bell Monday, with analysts expecting earnings of 12 cents per share on $538.2 million in revenue.

What To Know: Kabbani brings over 20 years of experience, including a long tenure at Amazon, where he was instrumental in launching Amazon Pharmacy, acquiring PillPack and leading logistics and digital media operations.

He also directed Amazon's global COVID-19 Vaccination Task Force and held executive roles at Flexport and Symbotic. CEO Andrew Dudum emphasized Kabbani's operational expertise as key to meeting growing demand and expanding the company's global infrastructure for accessible, tech-enabled care.

Kabbani expressed enthusiasm about building systems that deliver fast, reliable, and high-quality healthcare at scale.

What Else: The company in February reported fourth-quarter 2024 revenue of $481.14 million, exceeding expectations, and a subscriber base that grew 45% year-over-year to 2.2 million.

Despite a slight dip in gross margin to 77%, the company projects 2025 revenue between $2.3 and $2.4 billion and adjusted EBITDA up to $320 million.

Read Also: Wall Street Veteran Investor Lowers Recession Risk As US-China Trade War Cools

How To Buy HIMS Stock

By now you're likely curious about how to participate in the market for Hims & Hers Health ( HIMS ) – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.

In the case of Hims & Hers Health ( HIMS ), which is trading at $40.38 as of publishing time, $100 would buy you 2.48 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

According to data from Benzinga Pro, HIMS has a 52-week high of $72.98 and a 52-week low of $11.45.